SCHEMBL27033249

SCHEMBL27033249

Oc1ccc2c(c1O)OCO2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 2/20 0.53
CYP3A4 P08684 1/20 0.45
PSMB5 P28074 1/20 0.42
P4HB P07237 1/20 0.40
TXNRD1 Q16881 1/20 0.39
TXNRD3 Q86VQ6 1/20 0.39
TXNRD2 Q9NNW7 1/20 0.39
ABCG2 Q9UNQ0 1/20 0.39
TDP1 Q9NUW8 2/20 0.38
NPC1 O15118 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
ATM Q13315 1/20 0.38
HTR3E A5X5Y0 1/20 0.37
HTR3B O95264 1/20 0.37
HTR3A P46098 1/20 0.37
HTR3D Q70Z44 1/20 0.37
HTR3C Q8WXA8 1/20 0.37
KDM4C Q9H3R0 1/20 0.37
INSR P06213 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12023132 0.82 AOC3 (0.53) AOC3CYP3A4TXNRD1TXNRD3TXNRD2
SCHEMBL767958 0.78 AOC3 (0.50) AOC3CYP3A4TXNRD1TXNRD3TXNRD2
SCHEMBL25981475 0.78 AOC3 (0.54) AOC3CYP3A4P4HBTXNRD1TXNRD3
SCHEMBL4493536 0.78 AOC3 (0.50) AOC3CYP3A4P4HBTXNRD1TXNRD3
SCHEMBL767702 0.78 AOC3 (0.50) AOC3CYP3A4TXNRD1TXNRD3TXNRD2
SCHEMBL12613198 0.78 AOC3 (0.42) AOC3CYP3A4P4HBTXNRD1TXNRD3
SCHEMBL12119917 0.78 NQO2 (0.44) AOC3CYP3A4P4HBTXNRD1TXNRD3
SCHEMBL10430741 0.75 ERN1 (0.44) AOC3CYP3A4P4HBTXNRD1TXNRD3
SCHEMBL12023063 0.75 AOC3 (0.47) AOC3CYP3A4TXNRD1TXNRD3TXNRD2
SCHEMBL11086762 0.75 AOC3 (0.65) AOC3CYP3A4TXNRD1TXNRD3TXNRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208992-A1 MACROCYCLES AS CFTR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-06-27 US disclosed
EP-4308575-A1 MACROCYCLES AS CFTR MODULATORS Idorsia Pharmaceuticals Ltd (CH) 2024-01-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240208992-A1 MACROCYCLES AS CFTR MODULATORS CFTR, PKD1, ARRB1 AOC3 3106/4885CYP3A4 1162/4885PSMB5 1494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.